Skip to page content

Preventive Health Care

Commentary
A Case for Vaccinating Teachers First
Most agree that America's 18 million health care workers should top the list for COVID-19 vaccination. The 3.3 million teachers should come next. Vaccinating teachers could make it possible to open schools permanently and get parents back to work. That would help the economy recover.
Dec 19, 2020
Commentary
The Compensation System for Potential Side Effects Is an Important Part of a COVID-19 Vaccine Campaign
Concern about potential COVID-19 vaccine side effects and their consequences may be contributing to Americans' reluctance to get vaccinated. Policymakers and the public should carefully consider what types and levels of compensation for any adverse effects of vaccination are truly fair and appropriate.
Dec 18, 2020
Blog
Americans' Financial Struggles, COVID-19 Vaccinations, Virtual Schools: RAND Weekly Recap
This weekly recap focuses on Americans' ongoing financial struggles, how we can learn from the first phase of COVID-19 vaccinations, why virtual schools may be here to stay, and more.
Dec 18, 2020
Research Brief
The economic benefits of equitable global access to COVID-19 vaccines
Researchers used a global macroeconomic model to examine the economic effects of vaccine nationalism. This brief highlights the cost to 30 high-income countries if low and middle-income countries miss out on initial access to COVID-19 vaccines.
Dec 17, 2020
Commentary
COVID-19 Vaccination: Expect the Unexpected
With emergency use authorization for the first COVID-19 vaccine now in place, states and localities have turned their focus to the logistics of dispensing it as quickly as feasible. Still, uncertainties abound. It is essential to build a process of learning into the plan.
Dec 15, 2020
Blog
Civic Education, 'Vaccine Nationalism,' Polar Icebreakers: RAND Weekly Recap
This weekly recap focuses on how to revive civic education in America's public schools, the costs of
Dec 11, 2020
Blog
Restoring Public Trust, COVID-19 and Thanksgiving, Vaccinating Teachers: RAND Weekly Recap
This weekly recap focuses on how the Biden-Harris administration can restore public trust, the risk of Thanksgiving becoming a super-spreader event, why teachers should be among the first to get a COVID19 vaccination, and more.
Nov 26, 2020
Research Brief
Unequal Access to COVID-19 Vaccines Would Further Damage the Global Economy
As long as the coronavirus is not under control in all regions of the world there will continue to be a global economic cost associated with COVID-19. Vaccine nationalism could cost up to $1.2 trillion a year in GDP. If the poorest countries cannot access vaccines, the loss would be between $60 and $340 billion a year.
Nov 5, 2020
Essay
There's Help for Veterans with Mental Health and Substance Use Disorders
Many post-9/11 veterans who have PTSD or depression also struggle with substance use. There are clinically proven treatments to help break the cycle of the co-occurring disorders, but the VA and other facilities need guidance on how to expand and enhance treatment opportunities for these veterans.
Nov 4, 2020
Journal Article
Telehealth Capability in the U.S. at the Onset of COVID-19
Relatively few substance use treatment facilities in the United States offered telehealth services at the onset of the COVID-19 pandemic.
Nov 3, 2020
Blog
'Vaccine Nationalism,' a Pandemic Election, Women in the Workforce: RAND Weekly Recap
This weekly recap focuses on why 'vaccine nationalism' could be costly, how Americans feel about voting during a pandemic, why women are leaving the workforce, and more.
Oct 30, 2020
Report
COVID-19 'Vaccine Nationalism' Could Cost $1.2 Trillion a Year
Nationalistic behavior by governments may exclude some countries from access to COVID-19 vaccines. This could cost the world economy up to $1.2 trillion a year in GDP. A globally coordinated effort to fight the pandemic is key, not only from a public health perspective but also an economic one.
Oct 28, 2020
Multimedia
RAND Remote Series: Tackling an Evolving Pandemic
In this video conversation, Jennifer Bouey discusses RAND's rapid COVID-19 response, including insights and analysis to help strengthen and safeguard communities, rethink and retool institutions, and determine the best ways forward.
Oct 22, 2020
Journal Article
A Mixed-Method Comparison of Physician-Reported Beliefs About and Barriers to Treatment with Medications for Opioid Use Disorder
We conducted a mixed-methods study that involved focus group interviews and an online survey disseminated to a random group of licensed U.S. physicians, which oversampled physicians with a preexisting waiver to prescribe buprenorphine.
Oct 13, 2020
Blog
Health Care Price Transparency, COVID-19 Vaccinations, Gun Laws: RAND Weekly Recap
This weekly recap focuses on what private health plans pay compared to what Medicare pays, when COVID-19's global spread really began, laws that could reduce firearm deaths, and more.
Sep 25, 2020
Report
COVID-19 Vaccinations: Liability and Compensation Considerations for Policymakers
Vaccine development is only one part of the challenge in creating an immunization campaign to stop the pandemic. Once a safe and effective COVID-19 vaccine is ready, liability and compensation issues could affect its distribution and administration.
Sep 21, 2020
Journal Article
Study Design to Evaluate a Group-based Therapy for Support Persons of Adults on Buprenorphine/Naloxone
This study will evaluate whether the adapted intervention, also known as integrating support persons into recovery, is effective in increasing patient retention on buprenorphine when compared to usual care.
Sep 18, 2020
Journal Article
Health Center Implementation of Telemedicine for Opioid Use Disorders: A Qualitative Assessment of Adopters and Nonadopters
Although use of telemedicine for the treatment of opioid use disorders is growing, there is limited research on how it is actually being deployed in treatment. We explored how health centers across the U.S. are using it.
Sep 18, 2020
Multimedia
Sustainable Pharmaceutical Innovation for COVID-19 and Other Infectious Diseases
RAND Europe's Sonja Marjanovic describes the critical success criteria for innovation in infectious disease, antimicrobial, and vaccine research and development.
Sep 16, 2020
Commentary
PTSD and Substance Use Disorders Are a Vicious Cycle for Veterans
It is not uncommon to see a co-occurrence of PTSD and heavy use of substances, which can rise to the level of a substance use disorder. It may be necessary to challenge how the needs of veterans are addressed to remove barriers to care that make treating these co-occurring disorders simultaneously so difficult.
Sep 15, 2020

Previous
6
7
8
9
10
11
12
13
14
15
Next

Research conducted by

RAND Health Care

Researcher Spotlight

Mary Avriette

Assistant Policy Researcher and Ph.D. Candidate, Pardee RAND Graduate School

M. Avriette is a Ph.D. student in the Research, Analysis, and Design stream at the Pardee RAND Graduate School and an assistant policy researcher at RAND. She is an active-duty veterinarian in the U.S. Army. Her research interests include national security, developing-nation economics, zoonoses…
Jennifer Hawes-Dawson

Senior Survey Director, RAND Survey Research Group

Jennifer Hawes-Dawson (she/her) is an adjunct senior survey director in the RAND Survey Research Group (SRG) with more than 40 years experience managing primary data collection projects. She is experienced with all modes of quantitative and qualitative data collection: mail, telephone,…

Explore Our People »